Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Davis

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
Journal of Spine Surgery (Hong Kong)|January 15, 2021
Multi-modal pain control regimen for anterior lumbar fusion drastically reduces in-hospital opioid consumptionYoji Ogura, Jeffrey L Gum, Portia Steele, et al.
Blood Advances|August 19, 2024
Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapiesNardjas Bettazova, Jana Senavova, Kristyna Kupcova, et al.
Blood|June 7, 2013
Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftmentV Lokesh Battula, Ye Chen, Maria da Graca Cabreira, et al.
Molecular Cancer Research : MCR|February 14, 2023
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous LeukemiaSeemana Bhattacharya, Sujan Piya, Huaxian Ma, et al.
Scientific Reports|February 23, 2012
Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapyColleen M O'Connor, Sabina Sheppard, Cassie A Hartline, et al.
Leukemia|February 17, 2022
Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALLSujan Piya, Yaling Yang, Seemana Bhattacharya, et al.
Blood Advances|March 1, 2024
Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantationWarren B Fingrut, Eric Davis, Anne Archer, et al.
Blood Advances|April 12, 2021
Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AMLBrian C Shaffer, Jean-Benoit Le Luduec, Soo Park, et al.
Nature Communications|February 17, 2019
Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103<sup>+</sup> dendritic cell differentiationJun Yan, Qingnan Zhao, Konrad Gabrusiewicz, et al.
Cancer Research|June 3, 2005
Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomasLynda Song, Andrei Zlobin, Pushpankur Ghoshal, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Journal of Spine Surgery (Hong Kong)|January 15, 2021
Multi-modal pain control regimen for anterior lumbar fusion drastically reduces in-hospital opioid consumptionYoji Ogura, Jeffrey L Gum, Portia Steele, et al.
Blood Advances|August 19, 2024
Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapiesNardjas Bettazova, Jana Senavova, Kristyna Kupcova, et al.
Blood|June 7, 2013
Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftmentV Lokesh Battula, Ye Chen, Maria da Graca Cabreira, et al.
Molecular Cancer Research : MCR|February 14, 2023
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous LeukemiaSeemana Bhattacharya, Sujan Piya, Huaxian Ma, et al.
Scientific Reports|February 23, 2012
Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapyColleen M O'Connor, Sabina Sheppard, Cassie A Hartline, et al.
Leukemia|February 17, 2022
Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALLSujan Piya, Yaling Yang, Seemana Bhattacharya, et al.
Blood Advances|March 1, 2024
Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantationWarren B Fingrut, Eric Davis, Anne Archer, et al.
Blood Advances|April 12, 2021
Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AMLBrian C Shaffer, Jean-Benoit Le Luduec, Soo Park, et al.
Nature Communications|February 17, 2019
Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103<sup>+</sup> dendritic cell differentiationJun Yan, Qingnan Zhao, Konrad Gabrusiewicz, et al.
Cancer Research|June 3, 2005
Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomasLynda Song, Andrei Zlobin, Pushpankur Ghoshal, et al.
Pageof 17